Cocuzzi E, Piacentini M, Beninati S, Chung S I
Laboratory of Cellular Development & Oncology, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.
Biochem J. 1990 Feb 1;265(3):707-13. doi: 10.1042/bj2650707.
The major form of cross-link found in apolipoprotein B was identified as N1N12-bis-(gamma-glutamyl)spermine, a product known to be formed through the catalytic action of transglutaminases (EC 2.3.2.13). N1-(gamma-Glutamyl)spermine was present in a trace amount but epsilon-(gamma-glutamyl)lysine cross-links, which are formed during fibrin formation in plasma, were not detected. In the presence of catalytic amounts of plasma Factor XIIIa (a thrombin-dependent extracellular transglutaminase) or cellular transglutaminase (a cytosolic enzyme), apolipoprotein B and other plasma apolipoproteins (A-I, A-II and C) underwent covalently bridged polymerization and served as amine acceptor substrates. These results suggests that transglutaminases may participate in the covalent modification of apolipoproteins, either in the physiological state or during pathogenesis.
载脂蛋白B中发现的主要交联形式被鉴定为N1N12-双-(γ-谷氨酰基)精胺,已知该产物是通过转谷氨酰胺酶(EC 2.3.2.13)的催化作用形成的。N1-(γ-谷氨酰基)精胺含量微量,但未检测到血浆中纤维蛋白形成过程中产生的ε-(γ-谷氨酰基)赖氨酸交联。在催化量的血浆因子XIIIa(一种凝血酶依赖性细胞外转谷氨酰胺酶)或细胞转谷氨酰胺酶(一种胞质酶)存在的情况下,载脂蛋白B和其他血浆载脂蛋白(A-I、A-II和C)发生共价桥联聚合,并作为胺受体底物。这些结果表明,转谷氨酰胺酶可能在生理状态或发病过程中参与载脂蛋白的共价修饰。